Pirjo Laakkonen

Nanocrystal targeting <i>in vivo</i>

Maria E. Åkerman, Warren C. W. Chan, Pirjo Laakkonen et al. · Proceedings of the National Academy of Sciences · 2002 · 1.4K citations · Full text

Natural Sciences, Biomedical Engineering, Pharmaceutics +17

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

Tuomas Tammela, Georgia Zarkada, Elisabet Wallgard et al. · Nature · 2008 · 811 citations

Medicine, Molecular Biology, Oncology +14

A tumor-homing peptide with a targeting specificity related to lymphatic vessels

Pirjo Laakkonen, Kimmo Porkka, Jason A. Hoffman et al. · Nature Medicine · 2002 · 493 citations

Medicine, Oncology, Pharmaceutics +14

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

Sven Christian, Ján Pilch, Maria E. Åkerman et al. · The Journal of Cell Biology · 2003 · 488 citations · Full text

Medicine, Cancer Biology, Oncology +16

Lymphatic Neoangiogenesis in Human Kidney Transplants Is Associated with Immunologically Active Lymphocytic Infiltrates

Dontscho Kerjaschki, Heinrich M. Regele, Isabella Moosberger et al. · Journal of the American Society of Nephrology · 2004 · 478 citations

Medicine, Immunology, Pathology +17